RISK FACTORS FOR HYPERSENSITIVITY REACTIONS (HSRS) AMONG OVARIAN CANCER (EOC) PATIENTS TREATED WITH CARBOPLATIN-BASED CHEMOTHERAPY

被引：0
|
作者：
Jerzak, K. [1 ]
Manshadi, S. Deghan [1 ]
Ng, P. [2 ]
Maganti, M. [2 ]
McCuaig, J. M. [2 ]
Oza, A. [2 ]
Mackay, H. [2 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-0974
引用
收藏
页码：331 / 332
页数：2
相关论文
共 50 条
  • [11] Risk factors for and prognosis of carboplatin-related hypersensitivity in patients with epithelial ovarian cancer
    Woo Yeon Hwang
    Minjung Lee
    Dong Hoon Suh
    Kidong Kim
    Jae Hong No
    Yong Beom Kim
    Ju-Hyun Kim
    Archives of Gynecology and Obstetrics, 2022, 306 : 443 - 449
  • [12] Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer
    Takahiro Yoneyama
    Yuki Tobisawa
    Tohru Yoneyama
    Hayato Yamamoto
    Atsushi Imai
    Shingo Hatakeyama
    Yasuhiro Hashimoto
    Takuya Koie
    Chikara Ohyama
    International Journal of Clinical Oncology, 2015, 20 : 369 - 374
  • [13] Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer
    Yoneyama, Takahiro
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (02) : 369 - 374
  • [14] Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer
    Pickel, H
    Lahousen, M
    Petru, E
    Stettner, H
    Hackl, A
    Kapp, K
    Winter, R
    GYNECOLOGIC ONCOLOGY, 1999, 72 (02) : 215 - 219
  • [15] A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer
    Kaye, S. B.
    Poole, C. J.
    Danska-Bidzinska, A.
    Gianni, L.
    Del Conte, G.
    Gorbunova, V.
    Novikova, E.
    Strauss, A.
    Moczko, M.
    McNally, V. A.
    Ross, G.
    Vergote, I.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 145 - 152
  • [16] A randomised phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab (P) versus carboplatin-based therapy alone in patients with relapsed, platinum sensitive ovarian cancer
    Kaye, S. B.
    Poole, C. J.
    Bidzinksi, M.
    Gianni, L.
    Gorbunova, V.
    Novikova, E.
    Strauss, A.
    McNally, V. A.
    Ross, G.
    Vergote, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [17] Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy
    Markman, J
    Zanotti, K
    Webster, K
    Belinson, J
    Peterson, G
    Kulp, B
    Markman, M
    GYNECOLOGIC ONCOLOGY, 2004, 92 (02) : 592 - 595
  • [18] Carboplatin-based sequential chemotherapy for aged patients with advanced bladder cancer.
    Yoneyama, Takahiro
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yamamoto, Hayato
    Imai, Atsushi
    Mori, Kazuyuki
    Hatakeyama, Shingo
    Hashimoto, Yasuhiro
    Kole, Takuya
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [19] A cohort study of hypersensitivity reaction in patients with epithelial ovarian cancer treated with carboplatin
    Sun, Tingting
    Li, Lei
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (03) : 566 - 571
  • [20] ANALYSIS OF PATIENTS TREATED WITH CISPLATIN OR CARBOPLATIN-BASED DOUBLET CHEMOTHERAPY IN THE EUROPEAN FRAME OBSERVATIONAL STUDY
    Smit, E. F.
    Moro-Sibilot, D.
    De Castro Carpeno, J.
    Kmak-Lesniewski, K.
    Aerts, J. G.
    Villatoro, R.
    Kraaij, K.
    Nacerddine, K.
    Dyachkova, Y.
    Smith, K.
    Girvan, A.
    Visseren-Grul, C. M.
    Schnabel, P. A.
    ANNALS OF ONCOLOGY, 2014, 25
12345